Sentences with phrase «breast cancer studies found»

Similarly, 31 of the 45 breast cancer studies found such a trend.

Not exact matches

In a chapter dedicated to the work of the Life charity, studies on the link between abortion and breast cancer are discussed, as are findings that show rates of suicide and binge drinking are higher among women who have had abortions.

However, with the exception of women who consumed a high intake of soy during adolescence, the majority of epidemiological studies (studies carried out in defined population groups) have not found that women with higher soy intakes are at lower risk of breast cancer.

While there are studies that show soy might have some benefits for older women such as lowering cholesterol, easing menopausal symptoms, and reducing risk of breast cancer, other research casts doubt on these findings.

According to Kellymom.com, «studies have found a significant inverse association between duration of lactation and breast cancer.»

In fact, a study published by The Archives of Internal Medicine found that for women with an immediate family member who had breast cancer, those who breastfeed have a 59 % lower risk of developing breast cancer.

An international, collaborative study of almost 37,000 breast cancer cases published in the Annals of Oncology in October 2015 found a 20 percent reduction in risk of developing hormone - receptor negative breast cancer for women who breastfed.

Breastfeeding safe for women after breast cancer treatment, study finds.

However, one study suggests that using both may be best; it looked at cultures where women breastfed solely from one breast and found that the non-lactating breast had a higher incidence of breast cancer.

The researchers drew their findings from a larger study called the Western New York Exposure and Breast Cancer Sstudy called the Western New York Exposure and Breast Cancer StudyStudy.

A study of nearly 3,000 women conducted by researchers at the University of Buffalo in New York found women who experienced morning sickness during pregnancy were 30 percent less likely to have breast cancer later in life.

Reduced Risk of Some Cancers Studies have found the longer a mom breastfeeds, the more they are protected against breast and ovarian cancer.

In a study published in Cancer last year, Phipps and her colleagues found that certain breast cancer types may be rarer among women who breastfeed their babies for at least six mCancer last year, Phipps and her colleagues found that certain breast cancer types may be rarer among women who breastfeed their babies for at least six mcancer types may be rarer among women who breastfeed their babies for at least six months.

A study at the University of Wisconsin found that women who were breast fed in infancy may have a lower risk of developing breast cancer than those who were not breast fed.

In the first study evaluating patient - reported cosmetic outcomes in a population - based cohort of older women with breast cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long -cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long -Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long - term.

«Nonetheless, the proof of concept studies we have obtained thus far are extremely encouraging, and we are confident that with proper support and efforts we could translate our findings into experimental therapeutics for a variety of solid tumors that are driven by EphA2 overexpression, including breast, lung, prostate, pancreatic, and ovarian cancers,» said Pellecchia, who serves as the founding director of the Center for Molecular and Translational Medicine at UCR.

An earlier study that didn't take parental influence into account found one variant on chromosome 11 raised the risk of breast cancer by 7 per cent.

To find out more, UK - based researchers from the Universities of Leicester and Greenwich reviewed 24 publications reporting breast cancer screening practices in women with mental illness (around 700,000), and five studies investigating screening for those in distress but who had not been diagnosed with a mental illness (nearly 21,500).

But a major study by a Danish team, to be published this Saturday in The Lancet should help allay those fears: It found the risk of death among more than 5000 breast cancer survivors was no greater for those women who became pregnant.

In the Cell study, Dr. Massagué, with Fellow Manuel Valiente, PhD, and other team members, found that in mouse models of breast and lung cancer — two tumor types that often spread to the brain — many cancer cells that enter the brain are killed by astrocytes.

A single protein building block commonly found in food may hold a key to preventing the spread of an often - deadly type of breast cancer, according to a new multicenter study published today in the medical journal Nature.

Bloch's colleagues at the National Institute of Environmental Health Sciences tested the oils in gene expression studies on lab - grown human breast cancer cells and found that they could mimic estrogens, the primary female sex hormones, and inhibit androgens, the primary male sex hormones.

Isoflavones have been shown to slow the growth of breast cancer cells in laboratory studies, and epidemiological analyses in East Asian women with breast cancer found links between higher isoflavone intake and reduced mortality.

Extensive studies have found that 20 % to 30 % of breast cancers are characterized by over-expression of HER2, which makes the cancer cells grow and divide faster, leading to a cancer that's more aggressive and more likely to be resistant to the standard of care.

These carriers were found to have only a 56 % chance of developing breast cancer by age 70, compared with a figure of 87 % in previous studies.

The researchers found that only 16 % of women with a family history of breast cancer had BRCA1 mutations, compared with the 45 % found in previous studies.

To find BRCA mutations — which are very rare — most studies have examined families with very high rates of breast and other cancer in young family members.

The researchers found that these immune system pathways were suppressed in a large number of primary tumors — roughly 50 percent of ovarian cancers studied, 40 percent of colorectal cancers and 30 percent of breast cancers.

A recent study has found that in states with higher Medicaid payments for office visits, Medicaid beneficiaries were more likely to be screened for breast, cervical, and colorectal cancer.

The U.S. study testing the long - term benefits and risks of hormone replacement therapy (HRT) was halted after an interim analysis found that the drugs — a combination of estrogen and progestin — increased the risk of breast cancer, stroke, and heart disease, and that those risks outweighed reduced risks of colorectal cancer and bone fractures (ScienceNOW, 9 July).

«The findings of both studies support a growing body of research that suggests lifestyle interventions lower biomarkers associated with breast cancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stcancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stCancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stCancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both studies.

A pair of Yale Cancer Center interventional studies involving breast cancer survivors found that lifestyle changes in the form of healthy eating and regular exercise can decrease biomarkers related to breast cancer recurrence and mortCancer Center interventional studies involving breast cancer survivors found that lifestyle changes in the form of healthy eating and regular exercise can decrease biomarkers related to breast cancer recurrence and mortcancer survivors found that lifestyle changes in the form of healthy eating and regular exercise can decrease biomarkers related to breast cancer recurrence and mortcancer recurrence and mortality.

Heeke says the study would be open to people whose tumors have evidence of HRD like those found in this study, which includes bladder, breast, cervix, liver and bile duct, colorectal, endometrial, gastric / esophageal, head & neck, kidney, neuroendocrine, lung, ovarian, pancreas, prostate, sarcoma, and thyroid cancers, as well as gastrointestinal stromal tumors, glioma, melanoma and unknown primary cancers.

In earlier studies involving animal models and human cancer cell lines, researchers found that breast cancer spreads when three specific cells are in direct contact: an endothelial cell (a type of cell that lines the blood vessels), a perivascular macrophage (a type of immune cell found near blood vessels), and a tumor cell that produces high levels of Mena, a protein that enhances a cancer cell's ability to spread.

Professor Doug Easton from the University of Cambridge, one of the lead investigators on the study, says: «These findings add significantly to our understanding of the inherited basis of breast cancer.

The three Ras genes found in humans — H - Ras, K - Ras and N - Ras — were among the first to be linked to cancer development, and a new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prcancer development, and a new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prCancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prcancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected process.

Professor Peter Kraft at Harvard TH Chan School of Public Health, USA, says: «Given the size of these studies, we expected that we would find a lot of new breast cancer risk variants, but the studies tells us a lot more about which genes are involved, revealing many previously unsuspected genes and genetic mechanisms underlying breast carcinogenesis.

«Recent studies have reported supplemental cancer detection rates of 1.9 per 1,000 women screened with automated whole breast ultrasound and 1.2 to 2.8 per 1,000 women screened with digital breast tomosynthesis, so our finding of an additional 8.8 cancers per 1,000 women makes MBI a very compelling option for women who elect supplemental screening,» says Dr. Rhodes.

The study findings may have important implications for the diagnosis and treatment of breast cancer.

«The compelling results seen in this global study provide unequivocal evidence supporting the clinical utility of Oncotype DX to risk - stratify patients with early stage breast cancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medcancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of MedCancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medicine.

«These findings will give women with early stage breast cancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates CommCancer Research Advocates Committee.

In a new study, University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified genetic clues that explain how breast cancer spreads, or metastasizes — findings that may lead to better treatments or approaches to prevent its spread at the Cancer Center researchers have identified genetic clues that explain how breast cancer spreads, or metastasizes — findings that may lead to better treatments or approaches to prevent its spread at the cancer spreads, or metastasizes — findings that may lead to better treatments or approaches to prevent its spread at the onset.

«Our findings highlight the potential value for a randomized controlled trial of aspirin as an agent in early detection of breast cancer, particularly for women with naturally dense tissues who may be at an increased risk for certain cancers,» said Despina Kontos, PhD, assistant professor of Radiology, and co-author on the study.

The findings of the randomized study (S6 - 03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6 - 9, by Dr. Kerin Adelson, assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale - New Haven.

However, a separate study of black women finds a greater risk of breast cancer in women who took the hormone for 10 or more years than in women who had no hormone therapy.

In the 1980s, both US - based and international randomized clinical studies found that BCT and mastectomy offered women with early stage breast cancer equal survival benefit.

For instance, as early as the 1960s a number of studies have found that breast - feeding is associated with a lower risk of breast cancer, and more recent work suggests that this may be because breast milk supports the growth of beneficial microorganisms.

Mammography proponents, such as the American College of Radiology, contend that the study is fatally flawed because outdated mammography machines didn't find as many breast cancers as more advanced machines would.

The study findings defy the conventional belief that the two treatment interventions offer equal survival, and show the need to revisit some standards of breast cancer practice in the modern era.

Other studies have found that nutrients in dark, leafy greens may inhibit the growth of tumor cells in breast, skin, lung and stomach cancers and that green tea may thwart cancer development in colon, liver, breast and prostate cells.